The groundbreaking treatment of the medication represents a significant development in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide affects dual pathways – GLP-1 and glucose-dependent https://tirzepatidepeptide182033.bloginwi.com/75871907/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment